Medicinal Product Shortages - update - 17 July 2019

Notice type: Advisory

Date: 17/07/2019


Further Information:

The Health Products Regulatory Authority has been notified of a shortage of the following products:

  • Bupivacaine 2.5mg/ml Solution for Injection – PA2315/058/001
  • Bupivacaine 5mg/ml Solution for Injection – PA2315/058/002
  • Caverject 20mcg Powder & Solvent for Solution for Injection – PA0822/115/003
  • Etoposide 20mg/ml Concentration for Solution for Infusion - PA2315/207/001
  • Epanutin Ready Mixed Parenteral 250mg/5ml Solution for Injection or Infusion – PA0822/011/006
  • Floxapen 2000mg Powder for Solution for Injection or Infusion – PA1380/011/008
  • Innohep 8,000IU in 0.4ml Solution for Injection – PA0046/060/012
  • Innohep 12,000IU in 0.6ml Solution for Injection – PA0046/060/013
  • Mysoline 250mg Tablet – PA1777/001/001
  • Tranexamic acid 100mg/ml Solution for Injection – PA2315/178/001
  • Zineryt 40mg + 12mg Powder and Solvent for Cutaneous Solution – PA0046/065/001

The following shortage has been resolved and supply has resumed to the Irish market:

  • Elocon 0.1% w/w Ointment – PA1286/035/002
  • Flucol 200mg Capsule – PA0711/057/004
  • Gabapentin Rosemont 50mg/ml Oral Solution – PA0312/025/001
  • Olanzapine 7.5mg Tablet – EU/1/07/427/008/010
  • Tevaquel 50mg XL Prolonged Release Tablet – PA0749/060/006
  • Xanax 0.25mg Tablet – PA0822/141/002
  • Xanax 0.5mg Tablet – PA0822/141/003

Please see the shortages section of the 
HPRA website for further information.

The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.

« Back